Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

ARAY - ACCURAY INC

IEX Last Trade
1.935
0.005   0.258%

Share volume: 4,667
Last Updated: Thu 26 Dec 2024 08:29:16 PM CET
Surgical and Medical Instrument Manufacturing : 1.09%

PREVIOUS CLOSE
CHG
CHG%
$1.93
0.01
0.26%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
17%
Profitability 18%
Dept financing 28%
Liquidity 17%
Performance 15%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
3.74%
1 Month
-1.02%
3 Months
10.86%
6 Months
8.38%
1 Year
-34.68%
2 Year
-2.02%
Key data
Stock price
$1.94
P/E Ratio 
-10.07
DAY RANGE
$1.90 - $1.96
EPS 
-$0.22
52 WEEK RANGE
$1.47 - $2.99
52 WEEK CHANGE
-$33.33
MARKET CAP 
216.352 M
YIELD 
N/A
SHARES OUTSTANDING 
99.244 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
11/05/2024
BETA 
2.25
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$480,044
AVERAGE 30 VOLUME 
$620,872
Company detail
CEO: Suzanne C. Winter
Region: US
Website: accuray.com
Employees: 1,040
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Surgical and Medical Instrument Manufacturing
Sector: Manufacturing

Accuray Incorporated designs, develops, manufactures, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the Americas, Europe, the Middle East, India, Africa, Japan, China, and rest of the Asia Pacific region. The company also provides the TomoTherapy System, including the Radixact System.

Recent news